Pittsburgh, PA – According to filings with the U.S. Securities and Exchange Commission, Epistemix is raising $7,469,934.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, John Cordier played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Epistemix
Epistemix is a leading provider of analytical tools that empower leaders to make better decisions by simulating how diseases, ideas, and behavior spread through communities. We leverage decades of epidemiological experience, diverse datasets, realistic population dynamics, and scientific best-practice to build computational models that forecast the human impacts of policy interventions, so that organizations can take informed action. Our simulations have been used by groups like the Centers for Disease Control, the National Institutes of Health, and the World Health Organization. We are currently working with companies, event organizers, schools, and state and local governments across the United States to evaluate opening strategies and gauge COVID-19 response.

To learn more about Epistemix, visit http://www.epistemix.com/

Contact:
John Cordier, Chief Executive Officer
814-882-4185
john.cordier@epistemix.com
https://www.linkedin.com/in/johncordier/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved